1. Home
  2. DWSN vs VRCA Comparison

DWSN vs VRCA Comparison

Compare DWSN & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DWSN

Dawson Geophysical Company

HOLD

Current Price

$5.79

Market Cap

137.3M

Sector

Energy

ML Signal

HOLD

Logo Verrica Pharmaceuticals Inc.

VRCA

Verrica Pharmaceuticals Inc.

HOLD

Current Price

$6.10

Market Cap

117.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DWSN
VRCA
Founded
1952
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
137.3M
117.5M
IPO Year
1995
2018

Fundamental Metrics

Financial Performance
Metric
DWSN
VRCA
Price
$5.79
$6.10
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$17.00
AVG Volume (30 Days)
90.3K
38.1K
Earning Date
05-12-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
53.85
N/A
EPS
0.25
N/A
Revenue
$145,773,000.00
$35,577,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$94.44
P/E Ratio
$23.96
N/A
Revenue Growth
N/A
370.22
52 Week Low
$1.27
$0.70
52 Week High
$6.25
$9.82

Technical Indicators

Market Signals
Indicator
DWSN
VRCA
Relative Strength Index (RSI) 68.22 49.65
Support Level $1.75 $5.32
Resistance Level N/A $6.48
Average True Range (ATR) 0.43 0.49
MACD 0.13 0.04
Stochastic Oscillator 80.19 44.71

Price Performance

Historical Comparison
DWSN
VRCA

About DWSN Dawson Geophysical Company

Dawson Geophysical Co provides seismic data acquisition services mainly to providers of multi-client data libraries and directly to onshore oil and natural gas exploration and development companies in the continental U.S. and Canada. The demand for seismic services is largely influenced by drilling and completion activity, exploration budgets, and prevailing and anticipated crude oil and natural gas prices. Its data acquisition crews serve companies engaged in the exploration and development of oil and gas on land and in land-to-water transition areas. The business operates through two reportable segments, with U.S. operations generating the majority of revenue and Canada operations contributing additionally.

About VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.

Share on Social Networks: